Cancer in Hispanics in Los Angeles County.

Natl Cancer Inst Monogr

Published: December 1985

Using ethnicity of surname, nativity, residential social class, and inferred age at migration to characterize and subdivide Hispanics in Los Angeles, we compared risk ratios and proportional incidence ratios to examine the patterns of occurrence of selected neoplasms within the Hispanic community. Common neoplasms for which Hispanics have high, low, and intermediary risk were examined in detail. Although the patterns expected on the basis of current concepts of etiology were generally found and served to reinforce presumptions about the biologic significance of the risk factors, a number of observations cannot be explained easily with current knowledge. The risks for stomach and bowel cancers do not conform to the mirror-image patterns to be expected on the basis of inverse patterns of dietary acculturation. Incidence of cancer of the breast, in contrast to that of cervix, does not appear to reflect early cultural practice. Consistent details in the patterns of cancers of the bladder, rectum, ovary, prostate, and possibly pancreas imply unrecognized determinants of disease. Gallbladder cancer in Hispanic women is the disease most closely tied to Hispanic origin or culture, or both, but the ethnic pattern in women differs greatly from that in men.

Download full-text PDF

Source

Publication Analysis

Top Keywords

hispanics los
8
los angeles
8
patterns expected
8
expected basis
8
patterns
5
cancer hispanics
4
angeles county
4
county ethnicity
4
ethnicity surname
4
surname nativity
4

Similar Publications

Objective: We investigated associations between per- and polyfluoroalkyl substances (PFAS) and changes in diabetes indicators from pregnancy to 12 years after delivery among women with a history of gestational diabetes mellitus (GDM).

Research Design And Methods: Eighty Hispanic women with GDM history were followed from the third trimester of pregnancy to 12 years after delivery. Oral and intravenous glucose tolerance tests were conducted during follow-up.

View Article and Find Full Text PDF

Racial Disparities in Time to Huntington Disease Diagnosis in North America: An ENROLL-HD Analysis.

Neurol Clin Pract

October 2024

Department of Neurology (AM, YB, SLP), David Geffen School of Medicine; Institute for Society and Genetics (AM); Interdepartmental Undergraduate Neuroscience Program (AM), UCLA; Division of General Internal Medicine (ACO), Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO; Department of Neurology (YB), Cedars Sinai Health Center, Los Angeles, CA; and Division of General Internal Medicine and Health Services Research (AB), Department of Medicine, David Geffen School of Medicine, UCLA.

Background And Objectives: There are well-documented racial and ethnic disparities in access to neurologic care and disease-specific outcomes. Although contemporary clinical and neurogenetic understanding of Huntington disease (HD) is thanks to a decades-long study of a Venezuelan cohort, there are a limited number of studies that have evaluated racial and ethnic disparities in HD. The goal of this study was to evaluate disparities in time from symptom onset to time of diagnosis of HD.

View Article and Find Full Text PDF

Background: Race/ethnicity may affect outcomes in metastatic breast cancer (MBC) due to biological and social determinants. We evaluated the impact of race/ethnicity on clinical, socioeconomic, and genomic characteristics, clinical trial participation, and receipt of genotype-matched therapy among patients with MBC.

Methods: A retrospective study of patients with MBC who underwent cell-free DNA testing (cfDNA, Guardant360â, 74 gene panel) between 11/2016 and 11/2020 was conducted.

View Article and Find Full Text PDF

Neurodegeneration is presumed to be the pathological process measure most proximal to clinical symptom onset in Alzheimer Disease (AD). Structural MRI is routinely collected in research and clinical trial settings. Several quantitative MRI-based measures of atrophy have been proposed, but their low correspondence with each other has been previously documented.

View Article and Find Full Text PDF

Sudden cardiac death associated with fatty liver disease.

Int J Cardiol Heart Vasc

February 2025

Center for Cardiac Arrest Prevention, Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Health System, Los Angeles, CA, USA.

Background: Fatty liver disease or steatotic liver disease (SLD) affects 25% of the global population and has been associated with heart disease. However, there is a lack of postmortem studies in the context of sudden cardiac death (SCD).

Objectives: To investigate the relationship between SLD and SCD.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!